Highlights

  • De.mem Limited (ASX:DEM) reported approximately AUD 10.1 million in September-quarter customer receipts.
  • Net operating cash inflow reached AUD 842,000 in the September 2026 quarter.
  • Customer receipts totalled approximately AUD 30.1 million over the first nine months of 2026.
  • The company reported new specialty-chemical and water-treatment equipment orders.

De.mem Limited develops and supplies decentralised water and wastewater treatment systems, equipment, membranes and chemicals for industrial and other customers. On 20 October 2026, De.mem Limited (ASX:DEM) was quoted at AUD 0.11, down 8.33% in the trading session according to the specified market figures. Its October quarterly release described cash receipts, positive operating cash flow and new orders, making execution of existing service and supply work relevant to the company’s near-term operating picture.

Company Business

De.mem Limited (ASX:DEM) designs, builds, operates and maintains water and wastewater treatment equipment. Its offering includes treatment systems, membranes, pumps, filters and specialty chemicals, alongside recurring maintenance and operating services. The company serves clients across industries such as mining, manufacturing, food and beverages and other water-intensive activities. These markets require systems capable of treating process water, effluent or drinking water to meet specified operating requirements.

The group operates through Australian businesses and an international footprint that includes Germany and Singapore. The Australian activities include the Western Australian water-treatment and chemical supply businesses; the German operation supplies equipment to industrial customers. Its membrane technology development work supports the equipment and consumables portfolio, while routine chemical supply and maintenance contracts provide repeat customer activity.

Recent Development

In its September 2026 quarterly activities statement released in October, De.mem Limited (ASX:DEM) reported customer cash receipts of approximately AUD 10.1 million. It stated that receipts increased 29% against the comparable quarter. This was the thirtieth consecutive quarter in which cash receipts exceeded the year-earlier period, according to the company’s quarterly disclosure. More than 90% of receipts were described as recurring.

The group said its Western Australian businesses contributed approximately 47% of September-quarter receipts. Those operations include Core Chemicals, De.mem-Capic and Auswater Systems. The quarterly statement also described new customer additions and sales activity in specialty chemicals directed at mining customers.

During the September quarter, De.mem signed a framework agreement to supply antiscalants to an Australian mining customer. The company estimated its value at approximately AUD 800,000 over the following twelve months, with supply beginning in the December 2026 quarter. The agreement is terminable at convenience, which limits certainty over its ultimate value. Separately, the group disclosed two equipment orders: approximately AUD 350,000 for an Australian mining customer and approximately AUD 380,000 for an industrial customer of its German subsidiary. Both are expected to be delivered during 2027.

Financial Performance and Sector Context

De.mem Limited (ASX:DEM) recorded net operating cash inflow of AUD 842,000 in the September quarter, compared with AUD 424,000 in the June 2026 quarter and AUD 504,000 in the March 2026 quarter. Operating cash inflow for the nine months to September was AUD 1.77 million. Cash receipts over those nine months totalled approximately AUD 30.1 million, up around 28% against the comparative period.

The company reported approximately AUD 4.8 million of cash at 30 September 2026, versus approximately AUD 4.3 million at the end of June. Its Appendix 4C recorded September-quarter payments of AUD 5.93 million for product manufacturing and operating costs and AUD 2.67 million for staff costs. Cash receipts are not equivalent to recognised accounting revenue, while operating cash flow is distinct from net profit or EBITDA.

Demand for decentralised treatment equipment is tied to customer investment, water-handling requirements and industrial maintenance budgets. Specialty chemical supply also depends on operating levels at customer sites. The company’s mix of equipment orders and ongoing services exposes it to both contract delivery timing and repeat-consumable volumes.

Risks to Consider

The disclosed orders carry delivery and customer acceptance requirements. A framework agreement that can be terminated does not guarantee its full indicative value. Integration of acquired businesses, membrane product development, supplier costs and labour requirements can affect cash generation. Mining customers introduce exposure to changes in project schedules and operating demand. Quarterly receipts may also vary with payment timing, making comparisons with statutory revenue important.

What to Watch Next

The December 2026 quarter will provide an initial indication of supply under the new antiscalant framework. Subsequent updates may identify progress on the Australian and German equipment orders scheduled for 2027. Investors can also monitor the next Appendix 4C for cash receipts, payments, operating cash flow and cash balances, as well as the company’s next financial statements for revenue and earnings measures.

Key Insights

De.mem Limited (ASX:DEM) entered the final quarter of 2026 after reporting positive operating cash flow in each of the first three quarters and new contracts across its water-treatment business. Its September result reflected recurring customer receipts and activity in Western Australia. Conversion of orders into delivered revenue, the continuity of repeat sales and the relationship between operating cash flow and statutory profitability remain measurable developments.